SEARCH

SEARCH BY CITATION

References

  • Adam D (2002) Global antibiotic resistance in Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 50 (Suppl.), 15.
  • Appelbaum PC (2002) Resistance among Streptococcus pneumoniae: implications for drug selection. Clinical Infectious Diseases 34, 16131620.
  • Berkley JA, Lowe BS, Mwangi I et al. (2005) Bacteremia among children admitted to a rural hospital in Kenya. New England Journal of Medicine 352, 3947.
  • Black RE, Morris SS & Bryce J (2003) Where and why are 10 million children dying every year? The Lancet 361, 22262234.
  • Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW & Spratt BG (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. Journal Infectious Diseases 187, 14241432.
  • Campbell JD, Kotloff KL, Sow SO et al. (2004) Invasive pneumococcal infections among hospitalized children in Bamako, Mali. Pediatric Infectious Diseases Journal 23, 642649.
  • Cutts FT, Zaman SM, Enwere G et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. The Lancet 365, 11391146.
  • Feikin DR, Dowell SF, Nwanyanwu OC et al. (2000) Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine. Journal of Infectious Diseases 181, 15011505.
  • Garcia-Rodriguez JA & Fresnadillo-Martinez MJ (2002) Dynamics of nasopharyngeal colonization by potential respiratory pathogens. Journal of Antimicrobial Chemotherapy 50 (Suppl. S2), 5973.
  • Gordon SB, Kanyanda S, Walsh AL et al. (2003) Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi. Emerging Infectious Diseases 9, 747749.
  • Greenwood B (1999) The epidemiology of pneumococcal infection in children in the developing world philosophical. Transactions of the Royal Society of London. Series B: Biological Sciences 354, 777785.
  • Hausdorff WP (2002) Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. European Journal of Pediatrics 161, S135S139.
  • Hausdorff WP, Bryant J, Paradiso PR & Siber GR (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clinical Infectious Diseases 30, 100121.
  • Heikki P (2001) Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clinical Infectious Diseases 32, 6475.
  • Huebner RE, Wasas A, Mushi A, Mazhani L & Klugman KP (1998) Nasopharyngeal carriage and antimicrobial resistance in isolates of Streptococcus pneumoniae and Haemophilus influenzae type b in children under 5 years of age in Botswana. International Journal of Infectious Diseases 3, 1825.
  • Karstaedt AS, Khoosal M & Crewe-Brown HH (2000) Pneumococcal bacteremia during a decade in children in Soweto, South Africa. Pediatric Infectious Diseases Journal 19, 454457.
  • Klugman KP (1990) Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 3, 171196.
  • Klugman KP, Madhi SA, Huebner RE et al. (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. New England Journal of Medicine 349, 13411348.
  • Loscertales MP, Roca A, Ventura PJ et al. (2002) Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique. Pediatric Infectious Diseases Journal 1, 148155.
  • Madhi SA, Petersen K, Madhi A, Wasas A & Klugman KP (2000) Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatric Infectious Diseases Journal 19, 11411147.
  • National Committee for Clinical Laboratory Standards (2000a) Approved standard M7-A5. In: Methods for Dilution Antimicrobial Susceptibility Test for Bacterial that Grow Aerobically, 5th edn. NCCLS, Wayne, PA, pp. 17.
  • National Committee for Clinical Laboratory Standards (2000b) Approved standard M7-A. In: Performance Standards for Antimicrobial Disk Susceptibility Tests, 7th edn. NCCLS, Wayne, PA, pp. 20.
  • Poolman JT (2004) Pneumococcal vaccine development. Expert Review of Vaccines 3, 597604.
  • Robinson KA, Baughman W, Rothrock G et al. (2001) Epidemiology of invasive Streptococcus pneumoniae infection in the United States, 1995–1998: opportunities for prevention in conjugate vaccine era. The Journal of the American Medical Association 285, 17291735.
  • Rowe AK, Deming MS, Schwartz B et al. (2000) Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. Pediatric Infectious Diseases Journal 19, 438444.
  • Scott JA, Hall AJ, Dagan R et al. (1996) Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7000 episodes of invasive disease. Clinical Infectious Diseases 22, 973981.
  • Scott JA, Hall AJ, Dagan R et al. (1998) Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clinical Infectious Diseases 27, 14421450.
  • Westwood AT, Eley BS, Gilbert RD & Hanslo D (2000) Bacterial infection in children with HIV: a prospective study from Cape Town, South Africa. Annals of Tropical Paediatrics 20, 193198.
  • Whitney CG, Farley MM, Hadler J et al. (2003) Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. The New England Journal of Medicine 348, 17371746.